FDA has reviewed 30 postmarketing reports of acute pancreatitis in patients taking exenatide, a drug used to treat adults with type 2 diabetes. An association between Exenatide and acute pancreatitis is suspected in some of these cases.
Healthcare professionals should be alert to the signs and symptoms of acute pancreatitis and instruct patients taking Exenatide to seek prompt medical care if they experience unexplained, persistent, severe abdominal pain which may or may not be accompanied by vomiting. If pancreatitis is suspected, Exenatide should be discontinued. If pancreatitis is confirmed, Exenatide should not be restarted unless an alternative etiology is identified.
Source: http://www.fda.gov/cder/drug/infopage/exenatide/default.htm
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment